Literature DB >> 17294339

Cystic fibrosis in adults.

Ilma Aparecida Paschoal1, Wander de Oliveira Villalba, Carmen Sílvia Bertuzzo, Elza Maria F P Cerqueira, Mônica Corso Pereira.   

Abstract

The aim of this cross-sectional retrospective study was to describe clinical and functional characteristics and the microbiological profile of an adult population with cystic fibrosis. The study was performed at the Pulmonary Diseases Service of the Hospital of the Medical School of the State University of Campinas. The charts of 54 adults (27 males, 27 females) with cystic fibrosis were reviewed. Demographic, clinical, and microbiological data were collected. Clinical and functional characteristics of patients with chronic Pseudomonas infection were compared with those without it. The mean age of the patients was 41.8 years and the mean sweat chloride concentration was 106.4 mEq/L. Forty-nine percent had chronic respiratory symptoms only after 18 years of age, and 85% reported chronic production of purulent sputum. Six percent had diarrhea or fat in stools, and no patient suffered from diabetes mellitus. Pseudomonas was present in 48%, and 73% of them had the mucoid strain. Others agents found were Staphylococcus aureus (28%), Hemophylus sp. (34%), Aspergillus sp. (22%), Stenotrophomonas maltophilia (9%), Acinetobacter sp. (7%), and Burkholderia cepacia (2%). Nontuberculous mycobacteria were found in sputum from 9 patients (11%); 34 patients (67%) had obstructive ventilatory defect; and 47% had obstruction and restriction. Concerning the groups with and without Pseudomonas colonization, only the values of sweat chloride were significantly higher in chronic colonized patients. Less severe phenotypes of cystic fibrosis may be found among patients previously diagnosed as having bronchiectasis. Chronic colonization with Pseudomonas aeruginosa in this study was not associated with worse clinical status but colonized patients did show significantly higher levels of chloride in sweat.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17294339     DOI: 10.1007/s00408-006-2597-0

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  19 in total

1.  An investigation into causative factors in patients with bronchiectasis.

Authors:  M C Pasteur; S M Helliwell; S J Houghton; S C Webb; J E Foweraker; R A Coulden; C D Flower; D Bilton; M T Keogan
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

Review 2.  Relationship of airway epithelial ion transport to chronic bronchitis.

Authors:  Richard C Boucher
Journal:  Proc Am Thorac Soc       Date:  2004

Review 3.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests.

Authors:  H R Roberts; A U Wells; D G Milne; M B Rubens; J Kolbe; P J Cole; D M Hansell
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 6.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

7.  Primary ciliary dyskinesia: diagnostic and phenotypic features.

Authors:  Peadar G Noone; Margaret W Leigh; Aruna Sannuti; Susan L Minnix; Johnny L Carson; Milan Hazucha; Maimoona A Zariwala; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2003-12-04       Impact factor: 21.405

8.  Cystic fibrosis: current survival and population estimates to the year 2000.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

9.  Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.

Authors:  Irem S Patel; Ioannis Vlahos; Tom M A Wilkinson; Simon J Lloyd-Owen; Gavin C Donaldson; Mark Wilks; Rodney H Reznek; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2004-05-06       Impact factor: 21.405

10.  A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.

Authors:  M E Hodson; C G Gallagher; J R W Govan
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

View more
  5 in total

1.  Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients.

Authors:  Pedro Henrique Campanini Cândido; Luciana de Souza Nunes; Elizabeth Andrade Marques; Tânia Wrobel Folescu; Fábrice Santana Coelho; Vinicius Calado Nogueira de Moura; Marlei Gomes da Silva; Karen Machado Gomes; Maria Cristina da Silva Lourenço; Fábio Silva Aguiar; Fernanda Chitolina; Derek T Armstrong; Sylvia Cardoso Leão; Felipe Piedade Gonçalves Neves; Fernanda Carvalho de Queiroz Mello; Rafael Silva Duarte
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

2.  Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees.

Authors:  Ruella Rouf; Sara M Karaba; Jenny Dao; Nicholas P Cianciotto
Journal:  Microbiology (Reading)       Date:  2011-05-05       Impact factor: 2.777

3.  Modelling the bacterial communities associated with cystic fibrosis lung infections.

Authors:  T Spasenovski; M P Carroll; A K Lilley; M S Payne; K D Bruce
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-23       Impact factor: 3.267

4.  Volumetric capnography for the evaluation of pulmonary disease in adult patients with cystic fibrosis and noncystic fibrosis bronchiectasis.

Authors:  L Veronez; M M Moreira; S T P Soares; M C Pereira; M A G O Ribeiro; J D Ribeiro; R G G Terzi; L C Martins; I A Paschoal
Journal:  Lung       Date:  2010-01-05       Impact factor: 2.584

Review 5.  Infections in chronic lung diseases.

Authors:  G Iyer Parameswaran; Timothy F Murphy
Journal:  Infect Dis Clin North Am       Date:  2007-09       Impact factor: 5.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.